Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, today announced that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.

Coherus to buy Surface Oncology in stock deal valued at $65M

Coherus BioSciences is making a small stock-for-stock transaction to shore up its immuno-oncology pipeline in an acquisition of Surface Oncology that is valued at $65

June 17, 2023

New Strategies for Geographic Atrophy Show Early Promise

CHICAGO — An investigational dual-action inhibitor for geographic atrophy (GA) significantly slowed disease progression and improved visual acuity after 3 months of treatment, a small

October 22, 2024

Top FDA official Woodcock to retire early next year

Janet Woodcock, a top Food and Drug Administration official who had been on the short list to head the agency under President Joe Biden, will

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.